HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study.

AuthorsLorinda Chung, Katharine Ball, Aaliya Yaqub, Bharathi Lingala, David Fiorentino
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 71 Issue 2 Pg. 400-1 (Aug 2014) ISSN: 1097-6787 [Electronic] United States
PMID25037794 (Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelin A Receptor Antagonists
  • Phenylpropionates
  • Pyridazines
  • ambrisentan
Topics
  • Adult
  • Endothelin A Receptor Antagonists
  • Female
  • Fingers
  • Humans
  • Male
  • Middle Aged
  • Phenylpropionates (adverse effects, therapeutic use)
  • Pilot Projects
  • Prospective Studies
  • Pyridazines (adverse effects, therapeutic use)
  • Scleroderma, Systemic (complications)
  • Skin Ulcer (drug therapy, etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: